Leptospira santorosai serovar shermani detergent extract induces an increase in fibronectin production through a toll-like receptor 2-mediated pathway by Tian, Ya-Chung et al.
  Published Ahead of Print 20 December 2010. 
2011, 79(3):1134. DOI: 10.1128/IAI.01287-09. Infect. Immun. 
Yang
Hsiang-Hao Hsu, Mai-Szu Wu, Aled Phillips and Chih-Wei
Yung-Chang Chen, Ming-Yang Chang, Tzung-Hai Yen, 
Ya-Chung Tian, Cheng-Chieh Hung, Yi-Jung Li,
 
Receptor 2-Mediated Pathway 
Fibronectin Production through a Toll-Like
Detergent Extract Induces an Increase in 
 Serovar ShermaniLeptospira santorosai
http://iai.asm.org/content/79/3/1134
Updated information and services can be found at: 
These include:
REFERENCES
http://iai.asm.org/content/79/3/1134#ref-list-1at: 
This article cites 42 articles, 15 of which can be accessed free
CONTENT ALERTS
 more»articles cite this article), 
Receive: RSS Feeds, eTOCs, free email alerts (when new
http://journals.asm.org/site/misc/reprints.xhtmlInformation about commercial reprint orders: 
http://journals.asm.org/site/subscriptions/To subscribe to to another ASM Journal go to: 
 o
n
 February 24, 2014 by Cardiff Univ
http://iai.asm
.org/
D
ow
nloaded from
 
 o
n
 February 24, 2014 by Cardiff Univ
http://iai.asm
.org/
D
ow
nloaded from
 
INFECTION AND IMMUNITY, Mar. 2011, p. 1134–1142 Vol. 79, No. 3
0019-9567/11/$12.00 doi:10.1128/IAI.01287-09
Copyright © 2011, American Society for Microbiology. All Rights Reserved.
Leptospira santorosai Serovar Shermani Detergent Extract Induces an
Increase in Fibronectin Production through a Toll-Like
Receptor 2-Mediated Pathway
Ya-Chung Tian,1 Cheng-Chieh Hung,1 Yi-Jung Li,1 Yung-Chang Chen,1 Ming-Yang Chang,1
Tzung-Hai Yen,1 Hsiang-Hao Hsu,1 Mai-Szu Wu,1 Aled Phillips,2 and Chih-Wei Yang1*
Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Taipei and Taiwan, and
Chang Gung University, Tao Yuan, Taiwan,1 and Institute of Nephrology, Cardiff University, Wales, United Kingdom2
Received 17 November 2009/Returned for modification 4 January 2010/Accepted 29 November 2010
Leptospirosis can activate inflammatory responses through Toll-like receptors (TLRs) and may cause renal
tubulointerstitial fibrosis characterized by the accumulation of extracellular matrix (ECM). We have previ-
ously demonstrated that Leptospira santorosai serovar Shermani detergent extract stimulates ECM accumu-
lation in vitro. The aim of this study was to examine the mechanistic basis of these previous observations and,
in particular, to examine the potential involvement of TLRs. The addition of serovar Shermani detergent
extract led to an increase in fibronectin gene expression and production. Inhibition of TLR2 but not TLR4
expression abrogated serovar Shermani detergent extract-mediated increases in fibronectin production. This
response was also blocked by the knockdown of the gene expression of the TLR2 downstream transducers
myeloid differentiation factor 88 (MyD88) and tumor necrosis factor receptor-associated factor 6 (TRAF6).
Serovar Shermani detergent extract also activated nuclear factor-B, and its inhibition by curcumin-attenu-
ated serovar Shermani detergent extract induced increases in fibronectin production. These effects were also
mimicked by the specific TLR2 agonist, Pam(3)CsK(4), a response that was also abrogated by the knockdown
of MyD88 and TRAF6. Similarly, the administration of live leptospires to cells also induced fibronectin
production that was blocked by inhibition of TLR2 and MyD88 expression. In conclusion, serovar Shermani
detergent extract can induce fibronectin production through the TLR2-associated cascade, providing evidence
of an association between TLRs and leptospirosis-mediated ECM deposition.
Leptospirosis caused by leptospiral infection can result in
multiple-organ failure, including acute kidney injury (7). Al-
though tubulointerstitial nephritis is the most common histo-
logical finding in patients with leptospirosis, tubulointerstitial
fibrosis eventually develops if chronic leptospiral infection is
left untreated. While leptospirosis is well established as a cause
of tubulointerstitial fibrosis in dogs and rats, leading to chronic
renal failure (28, 30), it is also apparent that chronic leptospiral
infection may result in renal disease in humans (21). Persistent
infection may cause interstitial nephritis and fibrosis in human
biopsy samples (21), and more recent studies have demon-
strated that this may lead to end-stage renal failure (2). Lep-
tospira santorosai serovar Shermani (referred to hereafter as
serovar Shermani) is the main pathogenic leptospira causing
renal failure in Taiwan (4). We have recently demonstrated
that stimulation of proximal tubular cells with serovar Sher-
mani detergent extract stimulated the accumulation of extra-
cellular matrix (ECM) proteins such as type I and type IV
collagens, supporting the notion that leptospirosis can cause
tubulointerstitial fibrosis (32).
Toll-like receptors (TLRs) that recognize pathogen-associ-
ated molecular patterns are essential for the innate immune
response and play a fundamental role in antimicrobial re-
sponses against viruses and bacteria (1). For example, TLR2
and TLR4 have been implicated in cellular responses to lipo-
polysaccharide (LPS), and bacterial lipoproteins, the major
constituents of the Gram-negative bacterial outer membrane
(40). Binding of specific ligands to TLR2 leads to recruitment
of an intracellular adaptor protein, myeloid differentiation fac-
tor 88 (MyD88), which subsequently activates tumor necrosis
factor receptor-associated factor 6 (TRAF6) by phosphorylat-
ing interleukin-1 receptor-associated kinase 4 (IRAK-4) and
IRAK-1 (16). Finally, the nuclear factor-B (NF-B) and mi-
togen-activated protein kinase pathways are activated, thus
leading to induced inflammatory gene expression. It has been
shown that TLR4 enhances hepatic fibrogenesis (27). How-
ever, little is known about whether TLRs are implicated in the
development of renal fibrosis.
We previously demonstrated that serovar Shermani deter-
gent extract induces an increase in inflammatory cytokines and
chemokines through the TLR2-mediated but not the TLR4-
mediated pathway (36). It also stimulates ECM accumulation
through transforming growth factor  (TGF-)/Smad3-depen-
dent signaling pathway (32). Werts et al. also demonstrate that
L. interrogans outer membrane LPS and lipoproteins activate
macrophages through TLR2 in human cells (34). Nevertheless,
it remains unclear whether TLRs play a role in serovar Sher-
mani detergent extract-induced alteration of ECM molecules.
We show here that serovar Shermani detergent extract in-
creases fibronectin production via the TLR2-mediated path-
way, providing the first evidence that the TLR-associated sig-
naling pathways play an important role in ECM accumulation
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and implying a possible association between innate immunity
and renal fibrosis.
MATERIALS AND METHODS
Materials. Curcumin was purchased from Sigma-Aldrich (St. Louis, MO) and
6-amino-4-(4-phenoxyphenylethylamino)quinazoline (QNZ) was obtained from
Calbiochem (La Jolla, CA). Pam(3)CsK(4) was obtained from InvivoGen (San
Diego, CA). Anti-fibronectin antibody was purchased from Abcam (Cambridge,
United Kingdom).
Cell culture. Immortalized human renal proximal tubular cells, HK-2, were
cultured in Dulbecco modified Eagle medium/Ham F-12 (Life Technologies,
Paisley, United Kingdom) supplemented with 5% fetal calf serum (Biological
Industries, Ltd., Cumbernauld, United Kingdom), 2 mM glutamine (Life Tech-
nologies, Ltd., Paisley, United Kingdom), 20 mM HEPES buffer (Gibco-BRL,
Paisley, United Kingdom), 0.4 g of hydrocortisone/ml, 5 g of insulin/ml, 5 g
of transferrin/ml, and 5 ng of sodium selenite/ml (Sigma Chemical Company,
Ltd., Poole, United Kingdom).
To minimize the effect of serum-promoted cell proliferation and serum-me-
diated alteration of cell function and to avoid interference of serum-contained
fibronectin in fibronectin quantification, all experiments were performed under
serum-free conditions.
Live serovar Shermani was purchased from the American Type Culture Col-
lection (ATCC; Manassas, VA). Leptospires were cultured in medium contain-
ing 10% Leptospira enrichment Elinghausen-McCullough-Johnson-Harris
(EMJH) medium and 90% Leptospira medium base EMJM medium (Difco,
Sparks, MD) at 28°C for 5 to 7 days (14, 38). Prior to addition to the cells, the
number of leptospires was determined by direct counting in a counting chamber
under dark-field microscopy (18, 25).
Preparation of serovar Shermani detergent extract. The extraction method to
obtain L. santorosai serovar Shermani detergent extract has been described
previously (37). Briefly, serovar Shermani (ATCC 43286) was grown in 10%
EMJH leptospiral enrichment medium (Difco). Culture medium (500 ml) con-
taining 108 leptospires/ml enumerated by using dark field-microscopy was col-
lected (18). The serovar Shermani detergent extract was extracted with 1%
Triton X-114, 10 mM Tris (pH 8), and 1 mM EDTA. After centrifugation, the
hydrophobic fraction was collected, and 2% Triton X-114 was used for further
phase partitioning. After centrifugation for 10 min at 2,000  g, the aqueous
phases were removed, and the hydrophobic detergent fraction was precipitated
with acetone. The precipitant was then dissolved in water, resulting in a serovar
Shermani detergent extract yield of 250 g.
Gene silencing by siRNA. To knock down MyD88 and TRAF6 expression,
RNA interference was used to inhibit functions of MyD88 and TRAF6 mRNAs.
On-Target plus SMARTpool short interfering RNA (siRNA) of MyD88 and
TRAF6 was purchased from Dharmacon, Inc. (Lafayette, CO).
Briefly, 0.5 to 1.5 g of siRNA against MyD88 or TRAF6 or control siRNA
was diluted in serum-free medium to give a final volume of 100 l. Subsequently,
RNAiFectI transfection reagent was mixed with diluted siRNA at a ratio from
6:1 to 3:1. After incubation for 15 min at room temperature, the mixture was
added to the culture medium. After transfection for 24 h, cells were incubated in
the presence or absence of Leptospira santarosai serovar Shermani OMP under
serum-free condition for 24 or 48 h. Cells were then lysed and subjected to
real-time PCR or Western blot analysis.
Real-time PCR. The real-time PCR method has been previously described
(31). Briefly, total RNA was isolated from the cells and reverse transcribed to
DNA. Real-time PCR was performed according to the manufacturer’s instruc-
tions using an ABI Prism 7700 with SYBR green I as a double-stranded DNA-
specific dye (PE-Applied Biosystems, Cheshire, Great Britain). The primers used
to assay fibronectin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
transcript levels (fibronectin, 5-GTGTGACCCTCATGAGGCAAC-3 and 5-CT
GGCCTCCAAAGCATGTG-3; GAPDH, 5-TTCCAGGAGCGAGATCCCT-3
and 3-CACCCATGACGAACATGGG-5) were constructed to be compatible
with a single reverse transcription-PCR thermal profile (95°C for 10 min, 40
cycles at 95°C for 30 s, and 60°C for 1 min) (13). The accumulation of the PCR
product was monitored in real time (PE-Applied Biosystems). Experimental
results are presented as the transcript levels of the analyzed genes relative to
GAPDH transcript level.
Western blot analysis. Total cellular protein extraction was performed as
described previously (31). Equal amount of proteins were mixed with an equal
volume of reducing sodium dodecyl sulfate (SDS) sample buffer and boiled for
5 min at 95°C. Protein samples were resolved using SDS–10% polyacrylamide gel
electrophoresis (PAGE) and then electroblotted on nitrocellulose membranes
(Millipore, Billerica, MA). After electroblotting, nonspecific binding was blocked
with a 5% nonfat milk solution. The membrane was then incubated with primary
antibodies overnight at 4°C, followed by incubation with a horseradish peroxi-
dase-conjugated secondary antibodies for 1 h at room temperature. The proteins
were visualized by using enhanced chemiluminescence (Amersham Biosciences,
Amersham, United Kingdom). The same blot was reprobed with anti-tubulin
antibody (NeoMarkers, Fremont, CA) to examine tubulin expression as a con-
trol.
Electrophoretic mobility shift assay (EMSA). Nuclear proteins were prepared
according to the method of Satriano and Schlondorff (24). Briefly, cells were
harvested with trypsin and collected by centrifugation. Cell pellets were washed
with ice-cold phosphate-buffered saline (PBS) and suspended with buffer A
containing 10 mM HEPES (pH 7.9), 1.5 mM MgCl2, 10 mM KCl, 3.5 mM
dithiothreitol (DTT), and protease inhibitor (Complete; Boehringer Mann-
heim). Cell suspensions were incubated on ice for 10 min and centrifuged for 5
min at 650  g. The pellets were resuspended in the same buffer A containing
0.5% Nonidet P-40 on ice for 15 min and mixed by pipetting vigorously for lysis.
The nuclear fractions were pelleted for 5 min at 6,000  g and resuspended in
buffer B containing 5 mM HEPES (pH 7.9), 26% glycerol, 1.5 mM MgCl2, 0.2
mM EDTA, 0.5 mM DTT, and 0.4 M NaCl. After incubation on ice for 30 min
and centrifugation for 10 min at 12,000  g, the supernatants containing nuclear
protein were subsequently used.
Whole-cell nuclear extracts were subjected to assays for NF-B-binding activ-
ity using NF-B consensus oligonucleotide (59-AGTTGAGGGGACTTTAGG
C-39; Promega, Madison, WI) radiolabeled with [-32P]dATP by T4 polynucle-
otide kinase 3 (Amersham Pharmacia Biotech, Uppsala, Sweden). A total of 10
mg of nuclear protein was incubated with 70 to 80 kcpm of 32P-labeled NF-B
oligonucleotide in a binding mixture (50 mM HEPES [pH 7.9], 20% glycerol, 5
mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 250 mM NaCl, 0.5 mg of poly(dI-dC)
[Pharmacia Biotech], H2O) to a final volume of 15 ml. After incubation at room
temperature for 20 min, the protein-DNA complexes were resolved on native 4%
polyacrylamide gel in a Tris-borate-EDTA buffer system and run at 200 V for
1.5 h in a 4°C cold room. Gels were transferred to Whatman paper, dried, and
exposed to Kodak XR5 film (Rochester, NY) in film holders for 4 to 16 h at
280°C.
Immunohistochemistry. With the permission of the Ethics Committee of our
hospital, residual renal biopsy specimens in our tissue bank obtained from five
leptospirosis patients between January 2000 and December 2003 were analyzed
for the deposition of fibronectin and type I collagen. Normal tissues away from
the edge of renal cell carcinoma (RCC) obtained from five RCC patients un-
dergoing nephrectomy were used as negative controls. The average time from the
onset of leptospiral infection to the day of renal biopsy was 37  22 days.
Kidney specimens were fixed with 4% paraformaldehyde and embedded in
paraffin. After deparaffinization, sections were treated with 10 mM sodium
citrate and heated in a microwave for 10 min to expose antigenicities. Sec-
tions were then immersed in 3% H2O2 in methanol and blocked with 5%
bovine albumin-PBS for 20 min. After incubation with rabbit anti-fibronectin
or goat anti-type I collagen for 1 h, the sections were treated with relevant
biotin-conjugated antibodies, and the fibronectin or type I collagen immuno-
staining was then displayed by using a Vectastain ABC kit (Vector Labora-
tories, Burlingame, CA).
To quantify fibronectin immunostaining, the integrated image intensity in
eight consecutively selected nonoverlapping and area-fixed fields of renal cortex
and medulla at 400 magnification in each kidney specimen was calculated by
using MetaMorph imaging software (Molecular Devices Co., Sunnyvale, CA)
(33).
Statistical analysis. All data are presented as means  the standard error of
the mean. Statistical analysis was performed by using analysis of variance with
Tukey’s post hoc test. A P value of 0.05 was considered statistically significant.
RESULTS
L. santorosai serovar Shermani detergent extract induced an
increase in fibronectin gene expression and protein produc-
tion. To assess whether the pathogenic leptospira, serovar
Shermani increased fibronectin, we first assessed fibronectin
production after the addition of serovar Shermani detergent
extract to renal proximal tubular cells (HK-2 cells). After the
addition of 0.005 to 0.2 g of serovar Shermani detergent
extract/ml for 48 h, both real-time PCR and Western blot
analysis demonstrated a dose-dependent increase in fibronec-
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tin gene expression and protein, respectively (Fig. 1A and C).
Maximal increase in fibronectin gene expression and protein
production was seen after the addition of 0.1 g of serovar
Shermani detergent extract/ml. Similarly, addition of serovar
Shermani detergent extract led to a time-dependent increase
of fibronectin gene expression (Fig. 1B and D). Fibronectin
gene expression and protein production reached maximal re-
sponse after a 48-h stimulation.
Lipoproteins are the most abundant components in the lep-
tospiral total protein profile (5, 10, 42). To assess whether the
protein components are important for stimulation of fibronec-
tin production, serovar Shermani detergent extract was inacti-
vated by boiling for 30 min or treatment with proteinase K (100
to 200 M) at 37°C for 30 min. The result of Western blot
analysis demonstrated that the heat- or proteinase-pretreated
serovar Shermani detergent extract-stimulated fibronectin in-
duction was reduced compared to untreated leptospiral deter-
gent extract (Fig. 1E). This result suggests that the protein
components in serovar Shermani detergent extract may be
required to promote fibronectin production.
To determine whether fibronectin deposition is increased in
patients with leptospirosis, fibronectin immunostaining in kid-
ney specimens obtained from five patients with leptospiral
infection was assessed by immunohistochemistry. Renal histol-
ogy using hematoxylin and eosin (H&E) stain in leptospirosis
patients demonstrated prominent tubulointerstitial fibrosis
(Fig. 2B). Immunohistochemistry results showed that the fi-
bronectin immunostaining intensity was markedly increased in
the kidneys of patients with leptospiral infection (Fig. 2D)
compared to that in normal kidney tissues (Fig. 2C). Similarly,
type I collagen immunostaining intensity was also increased in
leptospirosis patients (data not shown). Immunostaining inten-
sity quantification results confirmed a significant increase in
fibronectin deposition in the kidneys of patients with leptospi-
rosis (Fig. 2G).
The serovar Shermani detergent extract-induced increase in
fibronectin production was mediated through TLR2. To define
the role of TLR2 and TLR4 in serovar Shermani detergent
extract-induced increase in fibronectin production, TLR2 and
TLR4 gene expressions were manipulated by gene silencing
using siRNA (12). Reduced TLR2 and TLR4 gene expression
was confirmed by real-time PCR (Fig. 3A and B). Both real-
time PCR and Western blot analysis showed that the suppres-
FIG. 1. Serovar Shermani detergent extract-induced increase in fibronectin production. (A and C) HK-2 cells were serum deprived for 24 h and
then grown in the presence or absence of different concentrations of serovar Shermani detergent extract (0.005 to 0.2 g/ml) under serum-free
condition for 2 days. (B and D) HK-2 cells were treated with 0.1 g of serovar Shermani detergent extract/ml for different periods as indicated.
Cells were incubated in serum-free medium for 72 h as a control (lane C). (E) Serovar Shermani detergent extract (0.1 g/ml) was inactivated by
boiling (100°C) for 30 min or pretreatment with proteinase K (100 to 200 M) at 37°C for 30 min and added to cells for further 2 days. Untreated
detergent extract was used as the control. Fibronectin gene expression was then quantified by real-time PCR (A and B). The results of real-time
PCR are expressed as the relative fold increase in fibronectin gene expression over that of the untreated group and presented as mean  the
standard error (SE) of triplicate measurements from four independent experiments (*, P  0.05 versus the untreated group). Cell lysate was
subjected to Western blot analysis for measurement of fibronectin production (C, D, and E). The results for one representative experiment of at
least three individual replicate experiments are shown.
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FIG. 2. Increased deposition of fibronectin immunostaining in the tubulointerstitium of patients with leptospirosis. The typical renal histology
of H&E staining in five leptospirosis patients is shown in panel B. Tubulointerstitial fibronectin deposition in these patients was assessed by
immunostaining for fibronectin, as shown in panel D. Normal tissues cut from residual kidney specimens obtained from five nephrectomized
patients with renal cell carcinoma were used as the control and stained for H&E staining (A) or fibronectin immunostaining (C). (E and F) A
negative control from normal tissues (E) and diseased tissues (F) for fibronectin immunostaining was performed using only the secondary antibody
with omission of the primary antibody (anti-fibronectin). (G) The integrated image intensity of fibronectin in eight consecutively selected
nonoverlapping and area-fixed fields at a 400 magnification in each kidney specimen was calculated as described in Materials and Methods. The
results are presented as the relative fold immunostaining intensity over that of the control  the SE (*, P  0.05, leptospirosis patients versus
control patients).
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sion of TLR2 expression reduced the serovar Shermani deter-
gent extract-induced increase in fibronectin production (Fig.
3C and D). In contrast, inhibition of TLR4 expression did not
affect this reaction.
The serovar Shermani detergent extract-induced increase in
fibronectin production was mediated through the TLR2-asso-
ciated signaling pathway. MyD88 and TRAF6 are important
downstream mediators of the TLR2-associated signaling path-
way (16). To assess whether MyD88 and TRAF6 are impli-
cated in the serovar Shermani detergent extract-induced in-
crease in fibronectin production, MyD88 and TRAF6 gene
expressions were knocked down by siRNA. The results of real-
time PCR and Western blot analysis demonstrated that inhi-
bition of MyD88 gene expression by MyD88 siRNA reduced
the serovar Shermani detergent extract-induced increase in
fibronectin expression and protein production (Fig. 4A and B).
In contrast, treatment with control siRNA did not affect this
response. Similarly, inhibition of TRAF6 expression by gene
silencing led to a reduction in the serovar Shermani detergent
extract-induced increase in fibronectin expression (Fig. 4C)
and protein production (Fig. 4D).
The serovar Shermani detergent extract-mediated increase
in fibronectin production required NF-B activation. It has
been shown that signal transduction of the TLR2-dependent
signaling pathway propagates through transcription factors, in-
cluding NF-B, to regulate the production of cytokines and
chemokines (15). The effect of serovar Shermani detergent
extract on NF-B activation was determined by EMSA to as-
sess the amount of NF-B binding to its consensus oligonucle-
otide. The results of EMSA demonstrated that addition of
serovar Shermani detergent extract led to an increase in
NF-B transcription factor binding to its specific oligonucleo-
tide (Fig. 5A). Enhancement of NF-B binding to its oligonu-
cleotide by serovar Shermani detergent extract was abrogated
by gene silencing of TLR2 but not TLR4.
To further determine whether NF-B was implicated in ser-
ovar Shermani detergent extract-induced increase in fibronec-
tin production, an NF-B inhibitor, curcumin, was used to
block NF-B activation prior to the administration of serovar
Shermani detergent extract. The results of Western blot anal-
ysis revealed that curcumin abrogated serovar Shermani deter-
gent extract-induced increase in fibronectin production in a
dose-dependent manner, suggesting an important role for
NF-B in this reaction (Fig. 5B). Similarly, another NF-B
activation inhibitor, QNZ, also inhibited serovar Shermani de-
tergent extract-induced increase in fibronectin production
(Fig. 5C).
A specific TLR2 agonist mimicked the effect of serovar
Shermani detergent extract on stimulation of fibronectin pro-
duction. Since serovar Shermani detergent extract-induced in-
crease in fibronectin production in HK-2 cells was mediated
through TLR2, we examined whether a specific TLR2 agonist,
Pam(3)CSK(4), could also stimulate increased fibronectin pro-
duction. After 48-h administration of Pam(3)CsK(4) to HK-2
cells, Western blot analysis demonstrated a dose-dependent
increase in fibronectin production (Fig. 6A). Specificity of the
TLR2 agonist-mediated increase in fibronectin production was
confirmed since inhibition of TLR2 but not TLR4 expression
blocked Pam(3)CsK(4)-stimulated fibronectin production
(Fig. 6B). Furthermore, inhibition of MyD88 gene expression
FIG. 3. Inhibition of serovar Shermani detergent extract-induced increase in fibronectin production by TLR2 gene silencing. HK-2 cells were
transfected with TLR2, TLR4, or scramble siRNA (mock) at a concentration of 100 nM for 24 h. Cells were then treated with serovar Shermani
detergent extract (0.1 g/ml) under serum-free condition for further 2 days. TLR2 (A), TLR4 (B), or fibronectin (C) mRNA expression was
determined by real time-PCR. The results are expressed as the mean relative fold increase in TLR2, TLR4, or fibronectin mRNA expression
compared to the mock transfection  the SE of triplicate measurements from four independent experiments (*, P  0.05 versus the mock
transfection; NS, no significance). (D) Fibronectin production was assessed by Western blot analysis. The results of one representative experiment
of at least three individual replicate experiments are shown.
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by 10 and 50 nM MyD88 siRNA or of TRAF6 gene expression
by 50 nM TRAF6 siRNA reduced the Pam(3)CsK(4)-induced
increase in fibronectin production (Fig. 6C).
Live serovar Shermani induced increased fibronectin pro-
duction mainly through TLR2 and MyD88. To assess whether
live leptospires can also induce fibronectin production, live
serovar Shermani was added to HK-2 cells. After 2-day admin-
istration of live serovar Shermani at different loads, the results
of Western blot analysis showed increased fibronectin produc-
tion in a dose-dependent manner (Fig. 7A). Since the major
component of serovar Shermani detergent extract in triggering
fibronectin production is TLR2 and MyD88 dependent (see
above), we determined whether TLR2 and MyD88 are also
required in live serovar Shermani-induced fibronectin produc-
tion. After 24-h administration of TLR2 and MyD88 siRNA,
live leptospires were added to cells for further 2 days. The
results showed that knockdown of either TLR2 or MyD88 gene
expression abrogated live serovar Shermani-induced fibronec-
tin production (Fig. 7B and C). In contrast, inhibition of TLR4
gene expression by siRNA did not block this response.
DISCUSSION
The kidney is the main target of acute or chronic leptospiral
infection (35). In humans, leptospiral infection has been shown
to cause tubulointerstitial fibrosis, leading to chronic renal
insufficiency and end-stage renal disease requiring hemodialy-
sis (2, 4). Although it has been well documented that tubulo-
interstitial fibrosis is an important consequence of leptospiral
infection in animal studies, the mechanism underlying this is
poorly defined. We previously showed that human renal prox-
imal tubular cells produce ECM proteins, including type I and
type IV collagens, in response to serovar Shermani detergent
extract stimulation (32). In the present study, we also demon-
strated that the addition of serovar Shermani detergent extract
to human renal proximal tubular cells led to an increase in
another ECM protein, fibronectin.
Although many profibrotic factors such as TGF-1 have
been observed to promote tissue fibrosis, innate immunity has
recently also been shown to play a crucial role in the develop-
ment and progression of tissue fibrosis (27). For example,
TLR4 has been implicated in hepatic fibrogenesis since TLR4
mutant mice develop less severe liver fibrosis after bile duct
ligation or thioacetamide injection compared to TLR4 wild-
type mice, indicating a requirement for TLR4 in the develop-
ment of liver fibrosis. In cases of pulmonary fibrosis, a conse-
quence of lung injury, Yang et al. have the demonstrated that
knockout or blockade of TLR2 expression by a TLR2-neutral-
izing antibody attenuates the progression of pulmonary fibrosis
induced by bleomycin, a TLR2 agonist (39). In the present
study, a serovar Shermani detergent extract-induced increase
in fibronectin was alleviated when TLR2 was knocked down by
TLR2 gene silencing. In contrast, TLR4 knockdown did not
alter the effect of serovar Shermani detergent extract on fi-
bronectin production. Furthermore, a specific TLR2 agonist
also induced an increase in fibronectin production, confirming
an association between the activation of innate immunity and
matrix deposition. We have previously demonstrated that ser-
ovar Shermani detergent extract induces increased inflamma-
tory chemokines such as nitric oxide (iNOS) and MCP-1
through TLR2 and not TLR4 in mouse proximal tubular cells.
FIG. 4. Inhibitory effect of MyD88 and TRAF6 gene silencing in serovar Shermani detergent extract-induced increase in fibronectin produc-
tion. HK-2 cells were transfected with MyD88 (A and B), TRAF6 (C and D), or scramble siRNA (control) at different concentrations (1 to 200
nM) for 24 h. Cells were then stimulated with serovar Shermani detergent extract (0.1 g/ml) under serum-free condition for further 2 days.
Fibronectin gene expression was assessed by real-time PCR (A and C), and protein production was determined by Western blot analysis (B and
D). The results of real-time PCR are expressed as the mean relative fold increase in fibronectin gene expression over that of the untreated group 
the SE of triplicate measurements from four independent experiments (*, P  0.05). The results of one representative result of Western blot
analysis of three individual replicate experiments are shown.
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The present study also identified a crucial role of TLR2 in
pathogenesis of leptospirosis-associated matrix deposition. Al-
though it is well documented that tubulointerstitial inflamma-
tion is closely associated with renal fibrosis (22), the molecular
link remains elusive. The present study suggests that innate
immunity may play a direct role in the initiation of both pro-
cesses.
Both MyD88 and TRAF6 are fundamental mediators of the
TLR-propagated cascade (17). MyD88 is an important adaptor
molecule that interacts directly with the TLRs on the cell
plasma membrane (19). In the present study, we demonstrate
that the serovar Shermani detergent extract-induced increase
in fibronectin production was attenuated by silencing MyD88
gene expression. It has been reported that bleomycin-induced
pulmonary fibrosis is significantly reduced in MyD88-deficient
mice (8). Furthermore, blockade of MyD88 by transfection of
rats with dominant-negative MyD88 results in a significant
reduction of cardiac hypertrophy and fibrosis in aortic band-
ing-induced pressure overload cardiac fibrosis (9). Similarly,
the present study also displayed that inhibition of TRAF6 by
gene silencing reduced serovar Shermani detergent extract-
induced increase in fibronectin production. Our study there-
fore suggests that both MyD88 and its downstream adaptor,
TRAF6, lie downstream of the serovar Shermani detergent
extract-induced activation of TLR and mediate subsequent
matrix deposition.
NF-B is a crucial transcription factor in the TLR-mediated
signaling pathways (41). Upon activation of TLR2 and its
downstream mediators MyD88 and TRAF6, cytoplasmic
NF-B is eventually translocated into the nucleus to trigger
targeted gene expression. We have previously shown that
serovar Shermani detergent extract can activate NF-B,
which causes an increase in inflammatory cytokines (37).
The present study demonstrated that serovar Shermani de-
tergent extract activated NF-B and that inhibition of
NF-B by curcumin abrogated the serovar Shermani deter-
gent extract-induced increase in fibronectin production. An
implied role of NF-B activation in liver fibrosis has been
documented (6). Chen et al. showed that inhibition of
NF-B by its inhibitor curcumin blocks LPS-induced in-
creased connective tissue growth factor and type I collagen
in cultured hepatic stellate cells, suggesting that NF-B is a
critical participant in hepatic fibrosis (3). Our data are con-
sistent with the work on hepatic fibrosis.
Lipoproteins are the most abundant components of the lep-
tospiral total protein profile (5, 10, 42). Over the past few
decades, several leptospiral lipoproteins have been shown to
be responsible for a leptospirosis-mediated immune response
FIG. 5. Suppressive effect of NF-B inhibition on the serovar Shermani detergent extract-induced increase in fibronectin production. (A) HK-2
cells were treated with serovar Shermani detergent extract (0.1 g/ml) in the presence or absence of TLR2 or TLR4 siRNA for 90 min. Mock
transfection with scramble siRNA was used as a negative control (cont.). Administration of Pam(3)CsK(4) (5 g/ml) to cells was used as an internal
positive control. The NF-B transcription factor binding to its consensus oligonucleotide was quantified by EMSA as described in Materials and
Methods. (B) Cells were stimulated with serovar Shermani detergent extract (0.1 g/ml) in the presence or absence of different concentrations of
curcumin (1 to 30 M) (B) or QNZ (10 nM) (C) for 2 days. Fibronectin production was determined by Western blot analysis. The results of one
representative experiment of at least three individual replicate experiments are shown.
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(26). In the present study, serovar Shermani detergent extract
after inactivation by pretreatment with heat or proteinase
failed to stimulate fibronectin production, suggesting that the
protein components in serovar Shermani detergent extracts
may play a role in promoting fibronectin production. Interest-
ingly, Roh et al. have demonstrated that different forms of
low-density lipoprotein enhance the synthesis of ECM pro-
teins, including fibronectin (23). Whether these findings and
our results share molecular mimicry requires further investi-
gation. Nevertheless, the outer membrane extraction method
used in the present study may concomitantly harvest protein
components and LPS from pathogenic leptospira (11). In fact,
the activity of serovar Shermani detergent extract in the stim-
ulation of fibronectin production was partially but not com-
pletely abolished by pretreatment with proteinase (Fig. 1E).
Since leptospiral LPS is also recognized by TLR2 (20), the
activity of serovar Shermani detergent extract could partly be
mediated by LPS contained in the extracts. It is a limitation of
the present study that we cannot determine the contribution of
leptospiral LPS to serovar Shermani detergent extract-induced
fibronectin production.
In the present study, live serovar Shermani also induced
fibronectin production that was abrogated by inhibition of
TLR2 and MyD88 expression. In line with the finding that
serovar Shermani detergent extract-induced fibronectin pro-
duction requires TLR2 and MyD88 functionalities, live lepto-
spire-induced fibronectin deposition also depends on TLR2
and MyD88.
It was recently shown that fibronectin proteolytic fragments
can upregulate TLR2 expression in human articular chondro-
cytes (29). In the present study, serovar Shermani detergent
extract promoted fibronectin production through TLR2. It re-
quires further elucidation whether the increase in fibronectin
production stimulated by serovar Shermani detergent extract
can subsequently enhance TLR2 upregulation, thus causing a
positive-feedback loop that amplifies leptospirosis-induced fi-
brosis.
In conclusion, we showed here that serovar Shermani deter-
gent extract can induce fibronectin production through the
TLR2-associated cascades, including its downstream adaptors,
MyD88 and TRAF6, and the transcription factor NF-B, pro-
viding evidence of an association between TLRs and leptospi-
rosis-mediated ECM deposition and implying an association
between innate immunity and renal fibrosis.
FIG. 6. Inhibition of specific TLR2 agonist-stimulated increase in
fibronectin production by knockdown of TLR2/MyD88/TRAF6.
(A) HK-2 cells were incubated in the presence or absence of
Pam(3)CsK(4) (0.5 to 5 g/ml) under serum-free conditions for 2 days.
The cell lysate was subsequently subjected to Western blot analysis to
determine fibronectin production. (B and C) HK-2 cells were trans-
fected with scramble siRNA (control), TLR2, or TLR4 at a concen-
tration of 100 nM (B) or with MyD88 or TRAF6 siRNA at different
concentrations as indicated (C) for 24 h. The cells were then incubated
in the presence or absence of Pam(3)CsK(4) (5 g/ml) for a further 2
days. Fibronectin production was assessed by Western blot analysis.
The results of one representative experiment of at least three individ-
ual replicate experiments are shown.
FIG. 7. Inhibition of live serovar Shermani-induced increase in fi-
bronectin production by TLR2 or MyD88 gene silencing. (A) HK-2
cells (106) were grown in the presence or absence of live serovar
Shermani (LS) from 102 to 106 leptospires under serum-free condition
for 2 days. (B and C) Cells (106) were transfected with 200 nM TLR2,
either TLR4 siRNA (B) or MyD88 siRNA (C), or scramble siRNA
(control) for 24 h. Live serovar Shermani (105 leptospires/ml) were
added to cells under serum-free condition for 2 days. At the end of the
experiments, cell lysates were subjected to Western blot analysis to
determine fibronectin production. The results of one representative
experiment of at least three individual replicate experiments are
shown.
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